Optimal Combination Therapy After Nevirapine Exposure.
Phase of Trial: Phase III
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir; Tenofovir dipivoxil fumarate; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms OCTANE; OCTANE-1
- 07 Jun 2017 Biomarkers information updated
- 08 Mar 2012 Extension study results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 11 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History